1.Entecavir for treatment of lamivudine-refractory chronic hepatitis B
Cheng WANG ; Jinjun CHEN ; Jian SUN
Medical Journal of Chinese People's Liberation Army 1983;0(05):-
12 months, baseline serum HBV DNA ≥104copies/ml) were prospectively followed. Virological and serologic responses and laboratory data of liver and renal function of each patient enrolled were monitored every three months. Entecavir resistant mutations were detected by direct sequencing of HBV reverse transcriptase region which was amplified by semi-nested polymerase chain reaction (PCR). HBV sequences of different genotypes obtained from GenBank were aligned to identify entecavir drug resistant substitutions. Results Of the 41 lamivudine refractory CHB patients who met the inclusion criteria, 16 patients (39%) achieved the point of undetectability in HBV DNA level (
2.Pretreatment of dondor dendritic cells with Ad-IL-12p35siRNA on the survival of allograft recipients
Jian-Fei LUO ; Bi-Cheng CHEN ; Zhong-Hua CHEN ;
Chinese Journal of Organ Transplantation 2005;0(10):-
Objective To explore the effects of donor dendritic cells(DC)treated with Ad-IL- 12p35siRNA on the survival of allogragft recipients.Methods The recombinant adenoviral vectors carrying IL-12p35siRNA and HKsiRNA were transfected into bone marrow derived DC of BALB/C murine.C57BL/6 recipients were infused with DG(Ad-IL-12p35siRNA DC,Ad-HKsiRNA DC and control DC)from BALB/C donors 7 days before cardiac allograft,the survival time of murine and the change of T_H 1 and T_H2(IL-2,IL-4,IL-10 and IFN-?)cytokine were observed.Results The survival time of p35 group(20.17?2.71)days was longer than that of control group(7.81?1.61)days and HK group(7.17?1.60)days.The concentration of IL-2 and IFN-?in p35 group were significantly lower than those of control group and HK group,otherwise were the concentration of IL-4 and IL-10. Conclusion Pretreatment of dondor dendritic ceils with Ad-IL-12p35siRNA could prolonged cardiac allograft survival in recipicents.
3.Construction of recombinant adenovirus vector expressing anti-VEGF hairpin ribozyme and human interleukin-24 and its cytotoxic effect on colon cancer HT-29 cells.
Shu-Jian CHANG ; Ji-Cheng YANG ; Wei-Chang CHEN
Chinese Journal of Oncology 2009;31(6):433-433
Adenoviridae
;
genetics
;
Cell Death
;
Genetic Vectors
;
HT29 Cells
;
Humans
;
Interleukins
;
biosynthesis
;
genetics
;
RNA, Catalytic
;
biosynthesis
;
genetics
;
RNA, Messenger
;
metabolism
;
Recombinant Proteins
;
biosynthesis
;
genetics
;
Transfection
;
Vascular Endothelial Growth Factor A
;
metabolism
4.Great attention should be paid to the adverse drug reactions associated with the use of molecular targeted anticancer drugs.
Zheng-tang CHEN ; Yu-zhong DUAN ; Jian-cheng XU
Chinese Journal of Oncology 2009;31(12):881-884
Antineoplastic Agents
;
adverse effects
;
therapeutic use
;
Diarrhea
;
chemically induced
;
Drug Delivery Systems
;
methods
;
Exanthema
;
chemically induced
;
Humans
;
Leukopenia
;
chemically induced
;
Lung Diseases, Interstitial
;
chemically induced
;
Myocardial Infarction
;
chemically induced
;
Neoplasms
;
drug therapy
;
Tumor Lysis Syndrome
;
etiology
5.Expression of cytokines Th1 and Th2 in patients with esophageal squamous cell carcinoma.
Peng-Cheng CHEN ; Jian-Guo FENG ; Yu-Tian LING
Chinese Journal of Oncology 2007;29(11):850-851
Adult
;
Aged
;
Aged, 80 and over
;
Carcinoma, Squamous Cell
;
immunology
;
pathology
;
Cytokines
;
blood
;
Esophageal Neoplasms
;
immunology
;
pathology
;
Female
;
Humans
;
Interferon-gamma
;
blood
;
Interleukin-10
;
blood
;
Interleukin-12
;
blood
;
Interleukin-4
;
blood
;
Interleukin-5
;
blood
;
Lymphatic Metastasis
;
Male
;
Middle Aged
;
Th1 Cells
;
immunology
;
Th2 Cells
;
immunology
;
Tumor Necrosis Factor-alpha
;
blood
7.Application and exploration of critical illness children interhospital transportation system
Weiming CHEN ; Guoping LU ; Jian MA ; Ye CHENG ; Gangfeng YAN
Chinese Pediatric Emergency Medicine 2015;22(5):295-299
Objective To investigate the value of the interhospital transportation and the advantage of the cooperative network to the critically ill children.Methods The clinical data of 232 critically ill chil-dren transported from other hospitals in long distances to PICU of Fudan University Affiliated Children Hos-pital cooperated with Shanghai 120 interprovincial transport Department,between Oct 2010 and Oct 2013, were analyzed retrospectively.Results At otal of 232 critically ill childrne were transported from 31 hospi-tals of Eastern China region including five provinces and the city of Shanghai.Among thse e critically ill chil-dren 141 casse were male and 91 cases were femla e,with age from 29 days ot 13 years( median age was 12 months) and weight from 2.5 to 66 kg ( median weight was 10 kg ) .The average pediatric clinical illness score was 80.4 ±7.7,155 cases(66.8%) were single organ dysfunction,55 cases(23.7%) were multiple organs dysfunction,105 cases(45.3%) were mechanical ventilation required fort ransportait on.Referral radi-us was 50-1 000 km(median).Among these patients,87 cases(37.3%) weret ransported over 200 km radius and73 cases(36%) were transop rted 101-200 km,62 cases(26.7%) were transported 100 km or less.D ur-ing the transportation,0 case died,3 cases(1.3%) received cardiopulmonary resuscitation treatment,2 cases (0.9%) received electrical conversion treatment,2 cases(0.9%) were replaced endotracheal intuab tion,the success rate of transportation was 100%.The top 4 disae ses were respiratro y id seases(90 cases,38.8%), neural diseases(43 cases,18.5%) ,cardiovascular diseases(36 cases,15.5%) and acute pediatric trauma(28 cases,12.1%) .Al l 232 cir tically ill children were admitted to our PICU for further treatment through the Green Channel.In the end, 178 cases ( 76.7%) discharged, 24 cases ( 10.3%) gave up and 32 cases (13.8%) died.Among thse e 232 rc itically ill children,30 cases(12.9%) received special organ replacement treatment,4 casse ( 1.7%) of whom were treated with extracorporeal membrane oxyg enation, 26 cases (11.1%) received blood purification therapy.Conclusion Establishing the system of transportation between PICU of hospitals will be propitious to treat the critically ill children energetically and effectively.It is worth pro-moting to master the transportation indication of children with critical illness,which is safe and reliable.
8.Aortic expression of HSP22, TNF-αand eNOS in rats with hyperlipi-demia and effects of atorvastatin
Haiyang FANG ; Qi CHEN ; Jian XIANG ; Yanqing WU ; Xiaoshu CHENG
Chinese Journal of Pathophysiology 2014;(10):1873-1878
AIM:To establish a rat hyperlipidemia model for studying the aortic expression of heat shock protein 22 (HSP22), tumor necrosis factor alpha (TNF-α) and endothelial nitric oxide synthase (eNOS) and the effect of atorvasta-tin intervention.METHODS:Hyperlipidemia model was established in SD rats.Afterwards, the rats were divided into nor-mal control group, high fat group and high fat+atorvastatin intervention group.The expression of HSP22 and TNF-αin the rat aortas was detected by immunohistochemical assay and the expression of eNOS was assessed by Western blotting.RE-SULTS:No detectable expression of HSP22 and TNF-αin the normal control group was observed.However, the expression of HSP22 and TNF-αwas positive in the high fat group and the atorvastatin intervention group.The mean densities of HSP22 and TNF-αpositive particles were significant lower in the atorvastatin intervention group as compared with high fat group ( both P<0.05) .The expression of eNOS protein in the high fat group and atorvastatin intervention group was significantly lower than that in normal control group (P<0.01).However, no marked difference of eNOS protein expression between high fat group and atorvastatins intervention group was observed.CONCLUSION:The expression of HSP22 and TNF-αin the rat aortas is increased in the hyperlipidemia rat model.This effect can be restored by atorvastatin treatment.The expression of eNOS in the rat aortas is decreased in the hyperlipidemia rat model, but this tendency could not be attenuated by atorvastatin.
9.The research on the expression and regulation of kallikrein 6 gene in human ovarian cancer cell
Fang ZHANG ; Ying-Jian CHEN ; Cheng-Jin HU ;
Chinese Journal of Laboratory Medicine 2001;0(04):-
Objective To investigate the effects of estrogen on the expression of KLK6 mRNA and protein in human ovarian cancer cell line HO8910.Methods HO8910 cells were incubated for 72 hours in two groups:the test group with 17-?E_2 at different concentration(10~(-10)、10~(-9)、10~(-8)、10~(-7)mol/L)and the control group with Ethanol.Real-time fluorensence quantitive RT-PCR and flow cytometry were used to measured the expression of KLK6 mRNA and protein in the two groups.The cell proliferation was measured by 3-(4,5-dimethylthiazol-z-yl)-2,5-dipheny tetrazolium blue(MTT)calorimetric assay,while the cell cycle was determined by flow cytometry.Results The expression ofKLK6 mRNA(3.83?0.41、4.14? 0.49、6.26?0.38、7.28?1.82)and protein(10.62?0.35,10.89?0.12、11.88?0.28、12.07?0.15) in the test group of H08910 cells(10~(-10)10~(-9)10~(-8)10~(-7)mol/L)was higher than that in the ethanol control group(P
10.The Roles of Drug-Fluting Stents in the Prevention and Treatment of Restenosis After Extracranial and Intracranial Stent Angioplasty
Jian-Hong WANG ; Cheng CHEN ; Fu-Qiang GUO ;
International Journal of Cerebrovascular Diseases 2006;0(10):-
Now symptomatic extracranial and intracranial stenting usually uses bare metal stents, but the incidence of restenosis is higher.The studies of drug-eluting stems for the treatment of coronary atherosclerosis have suggested that the incidence of restenosis decreases significantly. Although extracranial and intracranial drug-eluting stem placement appears to be safe,further large,prospective,randomized,controlled trials are needed to demonstrate its safety and effectiveness.